Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.06 (-7.63%)
Close on Nov 19, 2026Market cap $38.36MP/E –Yield –
Talphera gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Talphera's gross profit for the twelve months ending Dec 31, 2022 was -$2.59M. For fiscal 2022 it was -$2.59M. The highest annual figure on record is $17.49M in fiscal 2015.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$2.59M | – |
| FY2021 | Dec 31, 2021 | -$935.00K | – |
| FY2020 | Dec 31, 2020 | -$616.00K | – |
| FY2019 | Dec 31, 2019 | -$4.52M | – |
| FY2018 | Dec 31, 2018 | -$1.83M | – |
| FY2017 | Dec 31, 2017 | -$2.66M | -152.8% |
| FY2016 | Dec 31, 2016 | $5.04M | -71.2% |
| FY2015 | Dec 31, 2015 | $17.49M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$362.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$569.00K | -140.0% |
| Q2 FY2022 | Jun 30, 2022 | -$876.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$342.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.23M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.42M | – |
| Q2 FY2021 | Jun 30, 2021 | -$597.00K | -138.4% |
| Q1 FY2021 | Mar 31, 2021 | -$529.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$562.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$483.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $1.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.13M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.14M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.54M | – |
| Q2 FY2019 | Jun 30, 2019 | -$869.00K | -1359.4% |
| Q1 FY2019 | Mar 31, 2019 | -$965.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$625.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$498.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $69.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$771.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$222.00K | -106.8% |
| Q3 FY2017 | Sep 30, 2017 | -$542.00K | -168.9% |
| Q2 FY2017 | Jun 30, 2017 | -$884.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.02M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.27M | – |
| Q3 FY2016 | Sep 30, 2016 | $787.00K | – |
See a number that looks wrong?